Conditions: Hyperparathyroidism, Secondary
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 32
Healthy volunteers: yes

Brief summary:
The purpose of this study is to characterize the safety and tolerability of etelcalcetide in healthy young males.

Detailed description:

Arms:
arm 1: Participants received a single dose of placebo intravenous injection. arm 2: Participants received a single dose of etelcalcetide intravenous injection; the starting dose was 0.5 mg.

Interventions: intervention 1: Etelcalcetide intervention 2: Placebo
Intervention descriptions: intervention 1: Administered as a single intravenous (IV) injection intervention 2: Administered as a single intravenous (IV) injection

Protocol document: